DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC

M. Saksoe, K. Jensen, M. Andersen, J.G. Eriksen, J. Overgaard

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

3 Downloads (Pure)
OriginalsprogEngelsk
ArtikelnummerOC-041
TidsskriftRadiotherapy and Oncology
Vol/bind132
Udgave nummerSuppl. 1
Sider (fra-til)21-22
Antal sider2
ISSN0167-8140
DOI
StatusUdgivet - mar. 2019
Begivenhed7th ICHNO: International Conference on Innovative Approaches in Head & Neck Oncology - Barcelona, Spanien
Varighed: 14 mar. 201916 mar. 2019
Konferencens nummer: 7
https://www.esmo.org/Conferences/Past-Conferences/ICHNO-2019-Head-Neck-Cancer

Konference

Konference7th ICHNO: International Conference on Innovative Approaches in Head & Neck Oncology
Nummer7
LandSpanien
ByBarcelona
Periode14/03/201916/03/2019
Internetadresse

Citer dette

Saksoe, M. ; Jensen, K. ; Andersen, M. ; Eriksen, J.G. ; Overgaard, J. / DAHANCA 28a : Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC. I: Radiotherapy and Oncology. 2019 ; Bind 132, Nr. Suppl. 1. s. 21-22.
@article{03faa9700b884e158dd86316e19960b8,
title = "DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC",
author = "M. Saksoe and K. Jensen and M. Andersen and J.G. Eriksen and J. Overgaard",
year = "2019",
month = "3",
doi = "10.1016/S0167-8140(19)30207-5",
language = "English",
volume = "132",
pages = "21--22",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier",
number = "Suppl. 1",

}

DAHANCA 28a : Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC. / Saksoe, M.; Jensen, K.; Andersen, M.; Eriksen, J.G.; Overgaard, J.

I: Radiotherapy and Oncology, Bind 132, Nr. Suppl. 1, OC-041, 03.2019, s. 21-22.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - DAHANCA 28a

T2 - Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC

AU - Saksoe, M.

AU - Jensen, K.

AU - Andersen, M.

AU - Eriksen, J.G.

AU - Overgaard, J.

PY - 2019/3

Y1 - 2019/3

U2 - 10.1016/S0167-8140(19)30207-5

DO - 10.1016/S0167-8140(19)30207-5

M3 - Conference abstract in journal

VL - 132

SP - 21

EP - 22

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

IS - Suppl. 1

M1 - OC-041

ER -